Centre for Medical Psychology and Evidence-Based Decision-Making, University of Sydney, Sydney, New South Wales, Australia.
Oncologist. 2012;17(11):1475-81. doi: 10.1634/theoncologist.2012-0223. Epub 2012 Aug 29.
To explore the nondisclosure of complementary and alternative medicine (CAM) use among cancer patients, including reasons for and outcomes from nondisclosure of CAM use, within the context of patient-doctor communication.
A systematic review was conducted exploring investigations surrounding the communication of CAM use for patients with cancer published until August 2011.
A total of 21 studies were located, which reported a prevalence of CAM use among patients with cancer ranging between 11% and 95%; of these patients, 20% to 77% did not disclose their CAM use. The main reasons for nondisclosure were the doctor's lack of inquiry; patient's anticipation of the doctor's disapproval, disinterest, or inability to help; and patient's perception that disclosure of CAM use is irrelevant to their conventional care. There is some evidence to suggest that patient-doctor communication about the use of CAM was associated with an enhanced patient-doctor relationship and higher patient satisfaction.
Although the use of CAM by patients with cancer is high, patients frequently fail to disclose its use to their health professionals for reasons emanating from both sides of the dyadic patient-doctor relationship. Because a substantial proportion of patients with cancer may use CAM and there is potential for herb- or vitamin-drug interactions, further research in patient-doctor communication about CAM is necessary to maintain patient safety and wellbeing. The development of effective interventions to improve the disclosure of CAM use should be an integral part of this future research.
在医患沟通的背景下,探讨癌症患者隐瞒补充替代医学(CAM)使用情况的现象,包括隐瞒的原因和后果。
对截至 2011 年 8 月发表的有关癌症患者 CAM 使用情况沟通的研究进行了系统评价。
共发现 21 项研究,报告了癌症患者中 CAM 使用的流行率在 11%至 95%之间;在这些患者中,20%至 77%没有透露他们使用了 CAM。隐瞒的主要原因是医生缺乏询问;患者预期医生会不赞成、不感兴趣或无法提供帮助;以及患者认为披露 CAM 的使用与他们的常规治疗无关。有一些证据表明,患者与医生就 CAM 使用进行沟通与增强医患关系和提高患者满意度有关。
尽管癌症患者使用 CAM 的情况较为普遍,但出于医患关系双方的原因,患者经常未能向其医疗保健专业人员透露其使用情况。由于相当一部分癌症患者可能使用 CAM,并且存在草药或维生素-药物相互作用的潜在风险,因此有必要对 CAM 的医患沟通进行进一步研究,以维护患者的安全和健康。开发有效的干预措施以改善 CAM 使用情况的披露应成为未来研究的一个组成部分。